🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to reduce pulmonary complications in adult patient...
Status
Suspended
Location
University Of Abuja Teaching Hospital (Spoke)
Start Date
2022-05-16
Trial ID
NCT04386070
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of 4...
Status
Not Yet Recruiting
Location
Soweto HVTN CRS
Start Date
2026-07-13
Trial ID
NCT06613789
Treatments Being Tested
The purpose of this study is to determine safety and immunogenicity (abilit...
Status
Completed
Location
SGS Biopharma
Start Date
2003-12
Trial ID
NCT00482027
Treatments Being Tested
This is a randomized, placebo-controlled interventional study. The main pur...
Status
Completed
Location
Pharmaron
Start Date
2022-08-15
Trial ID
NCT05525546
The Objectives of this study is to evaluate the safety, pharmacokinetics an...
Status
Completed
Location
Seoul National University Hospital
Start Date
2013-08-06
Trial ID
NCT01855048
Treatments Being Tested
This trial will study a prime-boost vaccine approach designed mainly to ind...
Status
Completed
Location
St Stephen's Centre Chelsea and Westminster Hospital
Start Date
2008-11
Trial ID
NCT00902824
The goal of this multi-center, randomized, double-blind, placebo-controlled...
Status
Recruiting
Location
ARK Clinical Research, LLC
Start Date
2025-06-05
Trial ID
NCT07003984
Treatments Being Tested
The study will recruit up to 290 healthy adult males and non-pregnant femal...
Status
Completed
Location
Makerere University Walter Reed Project
Start Date
2019-10-07
Trial ID
NCT03910972
This study is the first administration of GSK2798745 in humans. This will b...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-06-09
Trial ID
NCT02119260
1. Eosinophilic asthma, a type 2 immune disorder, often involves the excess...
Status
Not Yet Recruiting
Location
Advagene Biopharma
Start Date
2025-12
Trial ID
NCT07250594
Treatments Being Tested